Entos Pharmaceuticals has been awarded federal money to conduct the phase 1 clinical trial of Covigenix, its COVID-19 DNA vaccine.

The PSA test for prostate cancer has been linked to unnecessary treatments and biopsies. That's prompted researchers to start developing a more accurate prostate cancer detection tool.